雅各臣科研製藥(02633.HK)擬分拆品牌保健護理業務於聯交所主板獨立上市
格隆匯1月20日丨雅各臣科研製藥(02633.HK)公佈,公司建議將其品牌保健護理業務分拆並尋求於香港聯合交易所有限公司主板獨立上市。為尋求此潛在分拆上市的進行,公司董事會已批准委聘相關專業人士,並批准企業重組,以重組控股公司旗下從事品牌護理保健業務的相關集團公司,新公司將作為潛在分拆上市的上市公司。根據聯交所證券上市規則第15項應用指引,分拆建議將於適時向聯交所呈交。
將予分拆的品牌保健護理業務預期包括品牌藥、品牌中藥以及品牌健康及保健產品,例如保健品、個人護理產品以及健康診斷套件。此潛在分拆上市預期將促進本公司以獨立平台擴充其非專利藥業務以外的品牌保健護理業務,而公司認為此有關業務分部分拆與公司發展策略一致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.